Urinary Bactericidal Activity of Extended-Release Ciprofloxacin (1,000 Milligrams) versus Levofloxacin (500 Milligrams) in Healthy Volunteers Receiving a Single Oral Dose

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial Agents and Chemotherapy 2006-11, Vol.50 (11), p.3947-3949
Hauptverfasser:	Wagenlehner, Florian M E, Kinzig-Schippers, Martina, Tischmeyer, Uwe, Wagenlehner, Christine, Sörgel, Fritz, Naber, Kurt G
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - pharmacology Antibiotics. Antiinfectious agents. Antiparasitic agents Area Under Curve Bacteria Biological and medical sciences Ciprofloxacin Ciprofloxacin - administration & dosage Ciprofloxacin - pharmacology Clinical Therapeutics Cross-Over Studies Delayed-Action Preparations Humans Levofloxacin Medical sciences Ofloxacin Ofloxacin - pharmacology Pharmacology. Drug treatments Proteus mirabilis Proteus mirabilis - drug effects Staphylococcus - drug effects Urine Urine - microbiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!